Messenger Ribonucleic Acid Quality Monitoring Market Outlook 2026–2030 Driven By Growth Factors And Projections
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Messenger Ribonucleic Acid Quality Monitoring Market Progress Between 2026 And 2030?
The messenger ribonucleic acid quality monitoring market has experienced rapid expansion in recent years. This market is set to increase from $1.47 billion in 2025 to $1.64 billion in 2026, at a compound annual growth rate (CAGR) of 11.3%. Historically, this growth can be ascribed to the broader range of mRNA research applications, the early integration of analytical validation tools, the expansion of academic and clinical research programs, the growing utilization of mRNA in vaccine development, and the provision of specialized quality control reagents.
The messenger ribonucleic acid quality monitoring market is poised for significant expansion in the coming years, with its size projected to reach $2.49 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.0%. This growth during the forecast period can be primarily attributed to factors such as the expansion of therapeutic mRNA pipelines, increasing regulatory scrutiny of mRNA products, growing investment in biopharmaceutical manufacturing, the rising adoption of real-time quality analytics, and the expansion of contract research and manufacturing services. Key trends anticipated within the same period encompass the increasing adoption of standardized mRNA quality control protocols, the rising use of advanced analytical instrumentation, growing integration of automated quality monitoring systems, expansion of regulatory compliance testing, and an enhanced focus on mRNA stability and integrity.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30321&type=smp
Which Major Drivers Are Influencing The Expansion Of The Messenger Ribonucleic Acid Quality Monitoring Market?
The future expansion of the messenger ribonucleic acid quality monitoring market is anticipated to be driven by the rising need for personalized medicines. Personalized medicines are defined as healthcare interventions specifically designed to match a patient’s unique genetic profile, way of life, and environmental factors, aiming for optimal therapeutic outcomes. This heightened demand for personalized treatments stems from the growing incidence of chronic and rare illnesses, which require specialized, patient-centric therapies to achieve better treatment results. Quality assurance for messenger ribonucleic acid is crucial for guaranteeing the precision, consistency, and effectiveness of mRNA-based treatments, thereby directly aiding in the creation of secure and potent personalized medicines. For example, data from February 2024, provided by the Personalized Medicine Coalition, a US-based non-profit entity, indicated that in 2023, the FDA granted approval to 16 novel personalized therapies for individuals suffering from rare diseases. This represents a significant increase compared to the six approvals noted in 2022. Consequently, the escalating need for personalized medicines is fueling the expansion of the messenger ribonucleic acid quality monitoring market.
What Are The Main Segments Within The Messenger Ribonucleic Acid Quality Monitoring Market Segment Structure?
The messenger ribonucleic acid quality monitoring market covered in this report is segmented –
1) By Type: Analytical Instruments, Reagents And Consumables, Software And Services
2) By Technology: Liquid Chromatography-Mass Spectrometry (LC-MS), Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Techniques, Other Technologies
3) By Application: Vaccine Development, Therapeutic Messenger Ribonucleic Acid Products, Gene Editing
4) By End User: Biopharmaceutical And Biotechnology Companies, Contract Development And Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs) And Analytical Labs, Academic And Research Institutes Or Centers
Subsegments:
1) By Analytical Instruments: Benchtop Analyzers, Microfluidic Systems, Spectrophotometers, Capillary Electrophoresis Systems
2) By Reagents And Consumables: Ribonucleic Acid Extraction Kits, Complementary Deoxyribonucleic Acid Synthesis Kits, Fluorescent Probes, Quality Control Standards
3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems, Consulting Services, Validation And Training Services
Which Trends Are Influencing Demand In The Messenger Ribonucleic Acid Quality Monitoring Market?
Major companies involved in messenger ribonucleic acid quality monitoring are emphasizing the development of innovative solutions, such as benchtop instruments, for the swift and accurate assessment of messenger ribonucleic acid quality attributes. A benchtop instrument is a compact laboratory device crafted to execute specialized analyses or experiments on a laboratory bench, providing convenience, speed, and accessibility without the necessity for large-scale equipment. For instance, in June 2024, InDevR Inc., a US-based biotechnology and analytical instrumentation company, launched 5’CapQ, a rapid benchtop assay intended for evaluating critical quality attributes (CQAs) of mRNA-based vaccines. This assay quantifies both the integrity and 5’ capping efficiency of mRNA molecules in under two hours, consolidating these vital quality metrics into a single streamlined test. It functions by selectively capturing mRNA molecules that have a 5’ cap and fluorescently labeling the poly(A) tail, thereby ensuring that only fully intact, capped mRNA, essential for stability and protein translation, is measured. By delivering fast, quantitative, and user-friendly analysis, 5’CapQ aids in eliminating testing bottlenecks in mRNA vaccine development without demanding specialized expertise or prolonged processing times.
Who Are The Companies Participating In The Messenger Ribonucleic Acid Quality Monitoring Market?
Major companies operating in the messenger ribonucleic acid quality monitoring market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Intertek Group plc, Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., WuXi Biologics (Cayman) Inc., QIAGEN N.V., Bio-Techne Corporation, Fujifilm Diosynth Biotechnologies, GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies Ltd., Creative Biolabs Inc., Creative Diagnostics, Jena Bioscience GmbH.
Get The Full Messenger Ribonucleic Acid Quality Monitoring Market Report:
Where Is The Messenger Ribonucleic Acid Quality Monitoring Market Most Concentrated Geographically?
North America was the largest region in the messenger ribonucleic acid quality monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid quality monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Messenger Ribonucleic Acid Quality Monitoring Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid Quality Monitoring Market 2026, By The Business Research Company
Ribonucleic Acid Rna Sequencing Market Report 2026
Dna Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report
Nucleic Acid Labeling Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
